Antonio Cañizo Outeiriño, del grupo FarmaCHUSLab, del IDIS logra el primer premio en el concurso “tus 3 minutesis” de BioIntegraSaúde 2024

La jornada, organizada por los tres institutos de investigación sanitaria de Galicia se celebró este año en el Hospital Álvaro Cunqueiro de Vigo

El IDIS dirige 7 de los 12 premios extraordinarios de doctorado de la USC en el área de Ciencias de la Salud

También ha sido reconocido otro trabajo del IDIS en el área de Ciencias e Ingenierías.

Frontiers publica un nuevo estudio sobre trastorno bipolar en que el que participa el grupo ITEN del IDIS

El estudio detectó una disminución las proteínas IGFBP-3 e IGFBP-5 en pacientes con trastorno bipolar, por lo que podrían ser posibles indicadores de la capacidad de respuesta al tratamiento o biomarcadores de diagnóstico en esos pacientes

News

Calendar

Load More

COMMON SUPPORT PLATFORMS

The platforms are research support units featured by a high strategic value, equipped by cutting edge technologies and operated by highly specialised technical staff.

CALLS

All updated information on public and private competitive calls. The most convenient and safest way to send your requests.

CAREERS

Would you like to join our team? We are always looking for people with a passion for research and propelled by insatiable curiosity to join our mission of providing a better healthcare day every day. Here you can see and apply for our current vacancies.

Research Areas

ONCOLOGY

Improvement of treatments: personalised therapy and reduction of side effects.

GENETICS AND SYSTEMS BIOLOGY

Identification of genetic biomarkers of disease susceptibility and prognosis

ENDOCRINOLOGÍA, NUTRICIÓN Y METABOLISMO

The area studies obesity from different perspectives with the participation of groups from the clinical and basic fields in a synergistic way.

NEUROSCIENCES

Search for new therapeutic targets and improvement of the clinical-therapeutic management of neurological patients, mainly stroke, Alzheimer’s, Parkinson’s disease, headaches and neurological diseases caused by prions.

CARDIOVASCULAR

The general objective of the Cardiovascular Area consists of the search for new therapeutic targets and the improvement of clinical-therapeutic management.

PLATFORMS AND METODOLOGY

The area aims at providing evidence for prioritising the management of public resources, evaluating risks and identifying opportunities for improving the health of the population. From here, prioritise structural investments and action programs.